![]() |

![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:1309551 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOL8 mRNA] | CTD | PMID:31150632 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1319953 | 6480464 | Ethinyl Estradiol results in increased expression of NOL8 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1319953 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOL8 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1319953 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOL8 mRNA | CTD | PMID:17942748 | 2,4-dinitrotoluene | affects expression | ISO | RGD:1309551 | 6480464 | 2, 4-dinitrotoluene affects the expression of NOL8 mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of NOL8 mRNA | CTD | PMID:21179406 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOL8 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL8 mRNA | CTD | PMID:28628672 | 4-amino-2,6-dinitrotoluene | affects expression | ISO | RGD:1309551 | 6480464 | 4-amino-2, 6-dinitrotoluene affects the expression of NOL8 mRNA | CTD | PMID:21346803 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1319953 | 6480464 | Fenretinide results in decreased expression of NOL8 mRNA | CTD | PMID:28973697 | aflatoxin B1 | increases expression | ISO | RGD:1319953 | 6480464 | Aflatoxin B1 results in increased expression of NOL8 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | ISO | RGD:1309551 | 6480464 | Tretinoin results in increased expression of NOL8 mRNA | CTD | PMID:20488242 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of NOL8 mRNA | CTD | PMID:24449571 | bisphenol A | increases expression | ISO | RGD:1309551 | 6480464 | bisphenol A results in increased expression of NOL8 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOL8 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL8 mRNA | CTD | PMID:28628672 | cadmium dichloride | decreases methylation | ISO | RGD:1309551 | 6480464 | Cadmium Chloride results in decreased methylation of NOL8 promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of NOL8 mRNA | CTD | PMID:26472689 | cadmium dichloride | decreases expression | ISO | RGD:1319953 | 6480464 | Cadmium Chloride results in decreased expression of NOL8 mRNA | CTD | PMID:24982889 | chromium(6+) | affects expression | ISO | RGD:1319953 | 6480464 | chromium hexavalent ion affects the expression of NOL8 mRNA | CTD | PMID:28472532 | cisplatin | multiple interactions | EXP | | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of NOL8 mRNA | CTD | PMID:21858171 | clofibric acid | multiple interactions | ISO | RGD:1309551 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOL8 mRNA | CTD | PMID:17602206 | coumarin | increases expression | ISO | RGD:1309551 | 6480464 | coumarin results in increased expression of NOL8 mRNA | CTD | PMID:18480146 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of NOL8 mRNA | CTD | PMID:20106945 more ... | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOL8 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL8 mRNA | CTD | PMID:28628672 | dibutyl phthalate | increases expression | ISO | RGD:1309551 | 6480464 | Dibutyl Phthalate results in increased expression of NOL8 mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of NOL8 mRNA | CTD | PMID:28302478 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NOL8 mRNA | CTD | PMID:29803840 | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of NOL8 mRNA | CTD | PMID:19244175 | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of NOL8 mRNA | CTD | PMID:19244175 | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NOL8 protein | CTD | PMID:23301498 | fluoranthene | multiple interactions | ISO | RGD:1319953 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of NOL8 mRNA | CTD | PMID:28329830 | furan | increases expression | ISO | RGD:1309551 | 6480464 | furan results in increased expression of NOL8 mRNA | CTD | PMID:26194646 | hexadecanoic acid | increases phosphorylation | EXP | | 6480464 | Palmitic Acid results in increased phosphorylation of NOL8 protein | CTD | PMID:28073184 | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of NOL8 mRNA | CTD | PMID:20044591, PMID:21179406 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOL8 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOL8 mRNA | CTD | PMID:28628672 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:1309551 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOL8 mRNA | CTD | PMID:17602206 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NOL8 mRNA | CTD | PMID:21420995 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of NOL8 mRNA | CTD | PMID:19159669 | phenobarbital | affects expression | ISO | RGD:1319953 | 6480464 | Phenobarbital affects the expression of NOL8 mRNA | CTD | PMID:23091169 | piroxicam | multiple interactions | EXP | | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of NOL8 mRNA | CTD | PMID:21858171 | propiconazole | increases expression | ISO | RGD:1319953 | 6480464 | propiconazole results in increased expression of NOL8 mRNA | CTD | PMID:21278054 | Salinomycin | decreases expression | EXP | | 6480464 | salinomycin results in decreased expression of NOL8 mRNA | CTD | PMID:19682730 | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of NOL8 mRNA | CTD | PMID:19244175 | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of NOL8 mRNA | CTD | PMID:19244175 | silicon dioxide | increases expression | ISO | RGD:1319953 | 6480464 | Silicon Dioxide results in increased expression of NOL8 mRNA | CTD | PMID:23221170 | sodium dichromate | increases expression | ISO | RGD:1309551 | 6480464 | sodium bichromate results in increased expression of NOL8 mRNA | CTD | PMID:25993096 | tacrolimus hydrate | increases expression | ISO | RGD:1319953 | 6480464 | Tacrolimus results in increased expression of NOL8 mRNA | CTD | PMID:25270620 | tetrachloromethane | increases expression | ISO | RGD:1319953 | 6480464 | Carbon Tetrachloride results in increased expression of NOL8 mRNA | CTD | PMID:27339419 | tetrachloromethane | increases expression | ISO | RGD:1309551 | 6480464 | Carbon Tetrachloride results in increased expression of NOL8 mRNA | CTD | PMID:30723492, PMID:31150632 | tetrachloromethane | multiple interactions | ISO | RGD:1309551 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOL8 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | RGD:1309551 | 6480464 | Thioacetamide results in increased expression of NOL8 mRNA | CTD | PMID:23411599 | troglitazone | decreases expression | ISO | RGD:1319953 | 6480464 | troglitazone results in decreased expression of NOL8 mRNA | CTD | PMID:28973697 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NOL8 mRNA | CTD | PMID:25979313 | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of NOL8 mRNA | CTD | PMID:19244175 | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of NOL8 mRNA | CTD | PMID:19244175 | |
|
|
|
|
|
|
|
|
|
|
1. | RGD automated import pipeline for gene-chemical interactions |
2. | Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11. |
PubMed | 8125298 10737800 11073942 14660641 14702039 15132771 15164053 15489334 16344560 16963496 17081983 18029348 19490893 20379614 21873635 22658674 22681889 26186194 26496610 27926873 28514442 29467281 29509190 29568061 30033366 30125550 |
NOL8 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nol8 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nol8 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nol8 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NOL8 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NOL8 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nol8 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NOL8 (Sus scrofa - pig) |
|
RH40358 |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_001256394 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_001330722 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_017948 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NR_046106 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006717166 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006717167 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006717169 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006717170 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006717172 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006717173 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_011518824 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_011518827 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014876 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014877 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014878 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014879 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014880 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447594 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447595 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XR_001746333 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XR_001746334 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AB105104 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AB109030 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK000743 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK001049 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK022755 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK024245 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK024786 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK225322 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK297355 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK307408 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL136097 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC008491 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC013788 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC035041 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC064942 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC146810 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BF906161 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BM475696 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471089 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CR627363 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DA470513 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DB227423 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
DB516208 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
KT584842 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001256394 ⟹ NP_001243323 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
CTTACGCCGACCTAGTCCAGGAATTGGTACACACAGCGATAGTGTTCAATAGAAACTAGGGGAThide sequence |
RefSeq Acc Id: | NM_001330722 ⟹ NP_001317651 | |||||||||
RefSeq Status: | VALIDATED | |||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CTTACGCCGACCTAGTCCAGGAATTGGTACACACAGCGATAGTGTTCAATAGAAACTAGGGGAThide sequence |
RefSeq Acc Id: | NM_017948 ⟹ NP_060418 | ||||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||||
Sequence: |
CTTACGCCGACCTAGTCCAGGAATTGGTACACACAGCGATAGTGTTCAATAGAAACTAGGGGAThide sequence |
RefSeq Acc Id: | NR_046106 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | NON-CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
CTTACGCCGACCTAGTCCAGGAATTGGTACACACAGCGATAGTGTTCAATAGAAACTAGGGGAThide sequence |
RefSeq Acc Id: | XM_006717166 ⟹ XP_006717229 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_006717167 ⟹ XP_006717230 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CTTACGCCGACCTAGTCCAGGAATTGGTACACACAGCGATAGTGTTCAATAGAAACTAGGGGAThide sequence |
RefSeq Acc Id: | XM_006717169 ⟹ XP_006717232 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_006717170 ⟹ XP_006717233 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_006717172 ⟹ XP_006717235 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_006717173 ⟹ XP_006717236 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_011518824 ⟹ XP_011517126 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_011518827 ⟹ XP_011517129 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GAAAGGTGGAACATTACAAATTCAACTAGCAAAAGAAAGCTTTCTGCACAGGAGGATATGGATAhide sequence |
RefSeq Acc Id: | XM_017014876 ⟹ XP_016870365 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_017014877 ⟹ XP_016870366 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_017014878 ⟹ XP_016870367 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_017014879 ⟹ XP_016870368 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CAGCGGCGCTGGCTTTAGAAAATTACTTTTCCCACTGAAACACACCCAAGTATATGCCCAGCCThide sequence |
RefSeq Acc Id: | XM_017014880 ⟹ XP_016870369 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_024447594 ⟹ XP_024303362 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XM_024447595 ⟹ XP_024303363 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CGTTGCTGACCGCAGCCGGGCCGGCAGCGCAGCTGTCACTCCGACCTGCGCGCTTCACCCGCGChide sequence |
RefSeq Acc Id: | XR_001746333 | |||||||||
RefSeq Status: | ||||||||||
Type: | NON-CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
ACGTGACCAGAAGTTAGGGGCTGCAGCGGCGCTGGCTTTAGGTGAACGACGTGAAAATTACTTThide sequence |
RefSeq Acc Id: | XR_001746334 | |||||||||
RefSeq Status: | ||||||||||
Type: | NON-CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
ACGTGACCAGAAGTTAGGGGCTGCAGCGGCGCTGGCTTTAGGTGAACGACGTGAAAATTACTTThide sequence |
Protein RefSeqs | NP_001243323 | (Get FASTA) | NCBI Sequence Viewer |
NP_001317651 | (Get FASTA) | NCBI Sequence Viewer | |
NP_060418 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006717229 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006717230 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006717232 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006717233 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006717235 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006717236 | (Get FASTA) | NCBI Sequence Viewer | |
XP_011517126 | (Get FASTA) | NCBI Sequence Viewer | |
XP_011517129 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870365 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870366 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870367 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870368 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870369 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303362 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303363 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAH13788 | (Get FASTA) | NCBI Sequence Viewer |
AAI46811 | (Get FASTA) | NCBI Sequence Viewer | |
BAA91356 | (Get FASTA) | NCBI Sequence Viewer | |
BAA91479 | (Get FASTA) | NCBI Sequence Viewer | |
BAB14229 | (Get FASTA) | NCBI Sequence Viewer | |
BAB14857 | (Get FASTA) | NCBI Sequence Viewer | |
BAB15003 | (Get FASTA) | NCBI Sequence Viewer | |
BAC99315 | (Get FASTA) | NCBI Sequence Viewer | |
BAD12268 | (Get FASTA) | NCBI Sequence Viewer | |
BAG59803 | (Get FASTA) | NCBI Sequence Viewer | |
CAH10464 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62814 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62815 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62816 | (Get FASTA) | NCBI Sequence Viewer | |
Q76FK4 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_060418 ⟸ NM_017948 |
- Peptide Label: | isoform a |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MKVNRETKRLYVGGLSQDISEADLQNQFSRFGEVSDVEIITRKDDQGNPQKVFAYINISVAEADhide sequence |
RefSeq Acc Id: | NP_001243323 ⟸ NM_001256394 |
- Peptide Label: | isoform b |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot), A6H8Z4 (UniProtKB/TrEMBL) |
- Sequence: |
MSVLNKTKWKGGTLQIQLAKESFLHRLAQEREAAKAKKEESTTGNANLLEKTGGVDFHMKAVPGhide sequence |
RefSeq Acc Id: | XP_006717230 ⟸ XM_006717167 |
- Peptide Label: | isoform X1 |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MKVNRETKRLYVGGLSQDISEADLQNQFSRFGEVSDVEIITRKDDQGNPQKVFAYINISVAEADhide sequence |
RefSeq Acc Id: | XP_006717229 ⟸ XM_006717166 |
- Peptide Label: | isoform X1 |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MKVNRETKRLYVGGLSQDISEADLQNQFSRFGEVSDVEIITRKDDQGNPQKVFAYINISVAEADhide sequence |
RefSeq Acc Id: | XP_006717235 ⟸ XM_006717172 |
- Peptide Label: | isoform X5 |
- Sequence: |
MKAVPGTEVPGHKNWVVSKFGRVLPVLHLKNQHKRKIIKYDPSKYCHNLKKIGEDFSNTIPISShide sequence |
RefSeq Acc Id: | XP_006717233 ⟸ XM_006717170 |
- Peptide Label: | isoform X3 |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MSVLNKTKWKGGTLQIQLAKESFLHRLAQEREAAKAKKEESTTGNANLLEKTGGVDFHMKAVPGhide sequence |
RefSeq Acc Id: | XP_006717236 ⟸ XM_006717173 |
- Peptide Label: | isoform X5 |
- Sequence: |
MKAVPGTEVPGHKNWVVSKFGRVLPVLHLKNQHKRKIIKYDPSKYCHNLKKIGEDFSNTIPISShide sequence |
RefSeq Acc Id: | XP_006717232 ⟸ XM_006717169 |
- Peptide Label: | isoform X3 |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MSVLNKTKWKGGTLQIQLAKESFLHRLAQEREAAKAKKEESTTGNANLLEKTGGVDFHMKAVPGhide sequence |
RefSeq Acc Id: | XP_011517126 ⟸ XM_011518824 |
- Peptide Label: | isoform X3 |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MSVLNKTKWKGGTLQIQLAKESFLHRLAQEREAAKAKKEESTTGNANLLEKTGGVDFHMKAVPGhide sequence |
RefSeq Acc Id: | XP_011517129 ⟸ XM_011518827 |
- Peptide Label: | isoform X5 |
- Sequence: |
MKAVPGTEVPGHKNWVVSKFGRVLPVLHLKNQHKRKIIKYDPSKYCHNLKKIGEDFSNTIPISShide sequence |
RefSeq Acc Id: | XP_016870369 ⟸ XM_017014880 |
- Peptide Label: | isoform X6 |
- Sequence: |
MKAVPGTEVPGHKNWVVSKFGRVLPVLHLKNQHKRKIIKYDPSKYCHNLKKIGEDFSNTIPISShide sequence |
RefSeq Acc Id: | XP_016870366 ⟸ XM_017014877 |
- Peptide Label: | isoform X4 |
- Sequence: |
MSVLNKTKWKGGTLQIQLAKESFLHRLAQEREAAKAKKEESTTGNANLLEKTGGVDFHMKAVPGhide sequence |
RefSeq Acc Id: | XP_016870367 ⟸ XM_017014878 |
- Peptide Label: | isoform X5 |
- Sequence: |
MKAVPGTEVPGHKNWVVSKFGRVLPVLHLKNQHKRKIIKYDPSKYCHNLKKIGEDFSNTIPISShide sequence |
RefSeq Acc Id: | XP_016870368 ⟸ XM_017014879 |
- Peptide Label: | isoform X5 |
- Sequence: |
MKAVPGTEVPGHKNWVVSKFGRVLPVLHLKNQHKRKIIKYDPSKYCHNLKKIGEDFSNTIPISShide sequence |
RefSeq Acc Id: | XP_016870365 ⟸ XM_017014876 |
- Peptide Label: | isoform X2 |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MKVNRETKRLYVGGLSQDISEADLQNQFSRFGEVSDVEIITRKDDQGNPQKVFAYINISVAEADhide sequence |
RefSeq Acc Id: | XP_024303362 ⟸ XM_024447594 |
- Peptide Label: | isoform X3 |
- Sequence: |
MSVLNKTKWKGGTLQIQLAKESFLHRLAQEREAAKAKKEESTTGNANLLEKTGGVDFHMKAVPGhide sequence |
RefSeq Acc Id: | XP_024303363 ⟸ XM_024447595 |
- Peptide Label: | isoform X5 |
- Sequence: |
MKAVPGTEVPGHKNWVVSKFGRVLPVLHLKNQHKRKIIKYDPSKYCHNLKKIGEDFSNTIPISShide sequence |
RefSeq Acc Id: | NP_001317651 ⟸ NM_001330722 |
- Peptide Label: | isoform c |
- UniProtKB: | Q76FK4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MKVNRETKRLYVGGLSQDISEADLQNQFSRFGEVSDVEIITRKDDQGNPQKVFAYINISVAEADhide sequence |
RGD ID: | 7215463 | |||||||||
Promoter ID: | EPDNEW_H13478 | |||||||||
Type: | initiation region | |||||||||
Name: | NOL8_1 | |||||||||
Description: | nucleolar protein 8 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7215467 | |||||||||
Promoter ID: | EPDNEW_H13480 | |||||||||
Type: | initiation region | |||||||||
Name: | NOL8_2 | |||||||||
Description: | nucleolar protein 8 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 6807922 | |||||||||
Promoter ID: | HG_KWN:64029 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | Lymphoblastoid | |||||||||
Transcripts: | ENST00000360868 | |||||||||
Position: |
|
RGD ID: | 6807616 | |||||||||
Promoter ID: | HG_KWN:64030 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | |||||||||
Transcripts: | ENST00000358855, ENST00000375594, NM_017948, NR_024020, OTTHUMT00000053074, OTTHUMT00000053076, OTTHUMT00000053077, OTTHUMT00000053078, OTTHUMT00000053079, OTTHUMT00000053080, UC004ARW.1, UC004ARX.1 | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | Global developmental delay [RCV000050347]|Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050348]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050348]|See cases [RCV000050348] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q22.31(chr9:91935027-92331095)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052234]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052234]|See cases [RCV000052234] | Chr9:91935027..92331095 [GRCh38] Chr9:94697309..95093377 [GRCh37] Chr9:93737130..94133198 [NCBI36] Chr9:9q22.31 |
uncertain significance |
GRCh38/hg38 9q22.31-22.33(chr9:91596533-97018746)x1 | copy number loss | Global developmental delay [RCV000052916]|See cases [RCV000052916] | Chr9:91596533..97018746 [GRCh38] Chr9:94358815..99781028 [GRCh37] Chr9:93398636..98820849 [NCBI36] Chr9:9q22.31-22.33 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124532)x3 | copy number gain | Intrauterine growth retardation [RCV000053745]|See cases [RCV000053745] | Chr9:193412..138124532 [GRCh38] Chr9:204193..141018984 [GRCh37] Chr9:194193..140138805 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138114463)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053746]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053746]|See cases [RCV000053746] | Chr9:193412..138114463 [GRCh38] Chr9:214367..141008915 [GRCh37] Chr9:204367..140128736 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|See cases [RCV000053748] | Chr9:193412..138179445 [GRCh38] Chr9:266045..141073897 [GRCh37] Chr9:256045..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q22.1-32(chr9:88522292-113687796)x3 | copy number gain | Global developmental delay [RCV000053752]|See cases [RCV000053752] | Chr9:88522292..113687796 [GRCh38] Chr9:91137207..116450076 [GRCh37] Chr9:90327027..115489897 [NCBI36] Chr9:9q22.1-32 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:204193-138179445) | copy number gain | See cases [RCV000133791] | Chr9:204193..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q21.11-31.2(chr9:68420430-106579493)x3 | copy number gain | See cases [RCV000136788] | Chr9:68420430..106579493 [GRCh38] Chr9:71130848..109341774 [GRCh37] Chr9:70225166..108381595 [NCBI36] Chr9:9q21.11-31.2 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124524)x3 | copy number gain | See cases [RCV000138783] | Chr9:193412..138124524 [GRCh38] Chr9:204090..141018976 [GRCh37] Chr9:194090..140138797 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p11.2-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000139207] | Chr9:193412..138159073 [GRCh38] Chr9:68420641..141053525 [GRCh37] Chr9:67910461..140173346 [NCBI36] Chr9:9p11.2-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000138962] | Chr9:193412..138159073 [GRCh38] Chr9:204104..141053525 [GRCh37] Chr9:194104..140173346 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic|conflicting data from submitters |
GRCh38/hg38 9q21.12-31.3(chr9:69627642-111454304)x3 | copy number gain | See cases [RCV000139789] | Chr9:69627642..111454304 [GRCh38] Chr9:72242558..114216584 [GRCh37] Chr9:71432378..113256405 [NCBI36] Chr9:9q21.12-31.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:203861-138125937)x3 | copy number gain | See cases [RCV000141876] | Chr9:203861..138125937 [GRCh38] Chr9:203861..141020389 [GRCh37] Chr9:193861..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q22.31(chr9:92094765-92337566)x3 | copy number gain | See cases [RCV000143043] | Chr9:92094765..92337566 [GRCh38] Chr9:94857047..95099848 [GRCh37] Chr9:93896868..94139669 [NCBI36] Chr9:9q22.31 |
uncertain significance |
GRCh38/hg38 9p24.3-q34.3(chr9:203862-138125937)x3 | copy number gain | See cases [RCV000143476] | Chr9:203862..138125937 [GRCh38] Chr9:203862..141020389 [GRCh37] Chr9:193862..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | See cases [RCV000148113] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q22.31(chr9:95051642-95264865)x3 | copy number gain | Ductal breast carcinoma [RCV000207122] | Chr9:95051642..95264865 [GRCh37] Chr9:9q22.31 |
uncertain significance |
GRCh38/hg38 9q22.31(chr9:92301666-92417555)x1 | copy number loss | Premature ovarian failure [RCV000225325] | Chr9:92301666..92417555 [GRCh38] Chr9:95063947..95179836 [GRCh37] Chr9:9q22.31 |
likely pathogenic|uncertain significance |
GRCh37/hg19 9p24.3-q34.3(chr9:163131-141122114)x3 | copy number gain | See cases [RCV000240081] | Chr9:163131..141122114 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:62525-141006407) | copy number gain | See cases [RCV000449375] | Chr9:62525..141006407 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020389)x3 | copy number gain | See cases [RCV000447207] | Chr9:203861..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203864-141020389)x3 | copy number gain | See cases [RCV000448978] | Chr9:203864..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q21.11-34.3(chr9:71069743-140999928) | copy number gain | Global developmental delay [RCV000626548]|Seizures [RCV000626548] | Chr9:71069743..140999928 [GRCh37] Chr9:9q21.11-34.3 |
likely pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203862-141020389) | copy number gain | See cases [RCV000512392] | Chr9:203862..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q22.31(chr9:94907633-96493970)x1 | copy number loss | not provided [RCV000683156] | Chr9:94907633..96493970 [GRCh37] Chr9:9q22.31 |
uncertain significance |
GRCh37/hg19 9q22.31(chr9:94974188-95228663)x3 | copy number gain | not provided [RCV000748524] | Chr9:94974188..95228663 [GRCh37] Chr9:9q22.31 |
benign |
GRCh37/hg19 9q22.31(chr9:95044229-95360764)x3 | copy number gain | not provided [RCV000748525] | Chr9:95044229..95360764 [GRCh37] Chr9:9q22.31 |
benign |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141122247)x3 | copy number gain | not provided [RCV000748055] | Chr9:10590..141122247 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141107672)x3 | copy number gain | not provided [RCV000748053] | Chr9:10590..141107672 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:46587-141066491)x3 | copy number gain | not provided [RCV000748063] | Chr9:46587..141066491 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141114095)x2 | copy number gain | not provided [RCV000748054] | Chr9:10590..141114095 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020388)x3 | copy number gain | not provided [RCV000845900] | Chr9:203861..141020388 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q21.2-22.32(chr9:79520825-97201274) | copy number gain | not provided [RCV000767645] | Chr9:79520825..97201274 [GRCh37] Chr9:9q21.2-22.32 |
pathogenic |
GRCh37/hg19 9q22.31(chr9:94667669-95345847)x3 | copy number gain | not provided [RCV000847811] | Chr9:94667669..95345847 [GRCh37] Chr9:9q22.31 |
uncertain significance |
GRCh37/hg19 9q21.11-34.3(chr9:71416475-141020389)x3 | copy number gain | not provided [RCV000847808] | Chr9:71416475..141020389 [GRCh37] Chr9:9q21.11-34.3 |
pathogenic |
GRCh37/hg19 9q22.31(chr9:95058076-95292831)x1 | copy number loss | not provided [RCV000847503] | Chr9:95058076..95292831 [GRCh37] Chr9:9q22.31 |
uncertain significance |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:23387 | AgrOrtholog |
COSMIC | NOL8 | COSMIC |
Ensembl Genes | ENSG00000198000 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000351723 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000354115 | UniProtKB/TrEMBL | |
ENSP00000388335 | UniProtKB/TrEMBL | |
ENSP00000390143 | UniProtKB/TrEMBL | |
ENSP00000390791 | UniProtKB/TrEMBL | |
ENSP00000401177 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000412471 | UniProtKB/TrEMBL | |
ENSP00000414112 | UniProtKB/TrEMBL | |
ENSP00000415750 | UniProtKB/TrEMBL | |
ENSP00000437615 | UniProtKB/TrEMBL | |
ENSP00000439751 | UniProtKB/TrEMBL | |
ENSP00000439829 | UniProtKB/TrEMBL | |
ENSP00000440342 | UniProtKB/TrEMBL | |
ENSP00000440709 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000441140 | UniProtKB/Swiss-Prot | |
ENSP00000441300 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000442037 | UniProtKB/TrEMBL | |
ENSP00000442596 | UniProtKB/TrEMBL | |
ENSP00000442666 | UniProtKB/TrEMBL | |
ENSP00000444790 | UniProtKB/TrEMBL | |
ENSP00000446265 | UniProtKB/TrEMBL | |
Ensembl Transcript | ENST00000358855 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000360868 | UniProtKB/TrEMBL | |
ENST00000411621 | UniProtKB/TrEMBL | |
ENST00000421075 | UniProtKB/TrEMBL | |
ENST00000432670 | UniProtKB/TrEMBL | |
ENST00000433029 | UniProtKB/TrEMBL | |
ENST00000434228 | UniProtKB/TrEMBL | |
ENST00000442668 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000445919 | UniProtKB/TrEMBL | |
ENST00000535387 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000535807 | UniProtKB/TrEMBL | |
ENST00000536593 | ENTREZGENE, UniProtKB/TrEMBL | |
ENST00000536624 | UniProtKB/TrEMBL | |
ENST00000542053 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000542573 | UniProtKB/TrEMBL | |
ENST00000542613 | UniProtKB/TrEMBL | |
ENST00000543260 | UniProtKB/TrEMBL | |
ENST00000544321 | UniProtKB/TrEMBL | |
ENST00000544867 | ENTREZGENE, UniProtKB/TrEMBL | |
ENST00000545444 | UniProtKB/TrEMBL | |
ENST00000545558 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 3.30.70.330 | UniProtKB/Swiss-Prot |
GTEx | ENSG00000198000 | GTEx |
HGNC ID | HGNC:23387 | ENTREZGENE |
Human Proteome Map | NOL8 | Human Proteome Map |
InterPro | NOP8_RRM | UniProtKB/Swiss-Prot |
Nucleotide-bd_a/b_plait_sf | UniProtKB/Swiss-Prot | |
RBD_domain_sf | UniProtKB/Swiss-Prot | |
RRM_dom | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:55035 | UniProtKB/Swiss-Prot |
NCBI Gene | 55035 | ENTREZGENE |
OMIM | 611534 | OMIM |
Pfam | RRM_1 | UniProtKB/Swiss-Prot |
PharmGKB | PA134918056 | PharmGKB |
PROSITE | RRM | UniProtKB/Swiss-Prot |
SMART | RRM | UniProtKB/Swiss-Prot |
Superfamily-SCOP | SSF54928 | UniProtKB/Swiss-Prot |
UniGene | Hs.442199 | ENTREZGENE |
UniProt | A0A024R250_HUMAN | UniProtKB/TrEMBL |
A0A0A0MSJ1_HUMAN | UniProtKB/TrEMBL | |
A6H8Z4 | ENTREZGENE, UniProtKB/TrEMBL | |
F5GWN9_HUMAN | UniProtKB/TrEMBL | |
F5GXV1_HUMAN | UniProtKB/TrEMBL | |
F5H0I5_HUMAN | UniProtKB/TrEMBL | |
F5H101_HUMAN | UniProtKB/TrEMBL | |
F5H532_HUMAN | UniProtKB/TrEMBL | |
F5H692_HUMAN | UniProtKB/TrEMBL | |
F5H797_HUMAN | UniProtKB/TrEMBL | |
F5H7D5_HUMAN | UniProtKB/TrEMBL | |
F5H8B8_HUMAN | UniProtKB/TrEMBL | |
F8WE42_HUMAN | UniProtKB/TrEMBL | |
NOL8_HUMAN | UniProtKB/Swiss-Prot, ENTREZGENE | |
UniProt Secondary | Q5TCC7 | UniProtKB/Swiss-Prot |
Q5TCC8 | UniProtKB/Swiss-Prot | |
Q5TCD3 | UniProtKB/Swiss-Prot | |
Q5TCD5 | UniProtKB/Swiss-Prot | |
Q5TCD6 | UniProtKB/Swiss-Prot | |
Q5TCD7 | UniProtKB/Swiss-Prot | |
Q76D35 | UniProtKB/Swiss-Prot | |
Q7L3E2 | UniProtKB/Swiss-Prot | |
Q9H586 | UniProtKB/Swiss-Prot | |
Q9H795 | UniProtKB/Swiss-Prot | |
Q9H7W7 | UniProtKB/Swiss-Prot | |
Q9H9J6 | UniProtKB/Swiss-Prot | |
Q9NWA4 | UniProtKB/Swiss-Prot | |
Q9NWM4 | UniProtKB/Swiss-Prot |
![]() |
More on NOL8 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 1319952 |
Created: | 2005-01-12 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.